N. H. KrikorianT.C. WallaceR. KrohnM.G. Bowman
The cardiac angiogenic response to FGF-2 treatment using clinically applicable methods was markedly inhibited in hypercholesterolemic swine with coronary endothelial dysfunction. These findings suggest that coronary endothelial dysfunction is major obstacle to the efficacy of clinical angiogenesis protocols and constitutes a target toward making angiogenesis more effective in patients with advanced coronary disease.
É. I. GolovkoL. F. OchkasM. S. Koval’chenkoA. F. Nikityuk
Yong SunSung-Hee LeeEdward EngbrechtKlaus PfeiferStephen D. SmithJohn WhiteJohn G. Ekerdt